Journals
Publish with us
Publishing partnerships
About us
Blog
Evidence-Based Complementary and Alternative Medicine
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Evidence-Based Complementary and Alternative Medicine
/
2017
/
Article
/
Tab 2
/
Review Article
Add-On Therapy with Traditional Chinese Medicine Improves Outcomes and Reduces Adverse Events in Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled Trials
Table 2
Solid tumor responses comparisons of HCC patients.
Comparisons
Studies
Groups
Clinical responses (%)
Heterogeneity
RR
95% CI
P
value
Chi
2
df
P
(%)
Complete response (CR)
[
22
,
23
,
29
,
30
,
32
,
34
–
36
]
Treatment
44/442 (10.0)
3.07
7
0.88
0
1.47
0.96–2.24
0.07
Control
26/406 (6.4)
Partial response (PR)
[
20
,
22
–
25
,
27
,
29
,
30
,
32
,
34
–
36
,
38
]
Treatment
210/610 (34.4)
9.96
12
0.62
0
1.30
1.10–1.53
0.002
Control
145/551 (26.3)
Stable disease (SD)
[
20
,
22
–
25
,
27
,
29
,
30
,
32
,
34
–
36
,
38
]
Treatment
260/610 (42.6)
15.89
12
0.2
24
0.95
0.84–1.08
0.47
Control
241/551 (43.7)
Progressive disease (PD)
[
20
,
22
–
25
,
27
,
29
,
30
,
32
,
34
–
36
,
38
]
Treatment
101/610 (16.6)
9.22
12
0.68
0
0.64
0.52–0.80
0.0001
Control
146/551 (26.5)
Total response rate (tRR)
[
20
,
22
–
25
,
27
,
29
,
30
,
32
,
34
–
36
,
38
]
Treatment
254/610 (41.6)
13.56
12
0.33
12
1.3
1.16–1.53
0.0001
Control
171/551 (31.0)